BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

NRX Pharmaceuticals, Inc. -0.40%

NRX Pharmaceuticals, Inc.

NRXP

2.51

-0.40%

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ: NRXP) with a Buy and maintains $25 price target.